Literature DB >> 16368756

A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme.

Dirk Roeser1, Andrea Preusser-Kunze, Bernhard Schmidt, Kathrin Gasow, Julia G Wittmann, Thomas Dierks, Kurt von Figura, Markus Georg Rudolph.   

Abstract

The formylglycine (FGly)-generating enzyme (FGE) uses molecular oxygen to oxidize a conserved cysteine residue in all eukaryotic sulfatases to the catalytically active FGly. Sulfatases degrade and remodel sulfate esters, and inactivity of FGE results in multiple sulfatase deficiency, a fatal disease. The previously determined FGE crystal structure revealed two crucial cysteine residues in the active site, one of which was thought to be implicated in substrate binding. The other cysteine residue partakes in a novel oxygenase mechanism that does not rely on any cofactors. Here, we present crystal structures of the individual FGE cysteine mutants and employ chemical probing of wild-type FGE, which defined the cysteines to differ strongly in their reactivity. This striking difference in reactivity is explained by the distinct roles of these cysteine residues in the catalytic mechanism. Hitherto, an enzyme-substrate complex as an essential cornerstone for the structural evaluation of the FGly formation mechanism has remained elusive. We also present two FGE-substrate complexes with pentamer and heptamer peptides that mimic sulfatases. The peptides isolate a small cavity that is a likely binding site for molecular oxygen and could host reactive oxygen intermediates during cysteine oxidation. Importantly, these FGE-peptide complexes directly unveil the molecular bases of FGE substrate binding and specificity. Because of the conserved nature of FGE sequences in other organisms, this binding mechanism is of general validity. Furthermore, several disease-causing mutations in both FGE and sulfatases are explained by this binding mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368756      PMCID: PMC1324989          DOI: 10.1073/pnas.0507592102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases.

Authors:  T Dierks; M R Lecca; P Schlotterhose; B Schmidt; K von Figura
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Molecular characterization of the human Calpha-formylglycine-generating enzyme.

Authors:  Andrea Preusser-Kunze; Malaiyalam Mariappan; Bernhard Schmidt; Santosh Lakshmi Gande; Kudzai Mutenda; Dirk Wenzel; Kurt von Figura; Thomas Dierks
Journal:  J Biol Chem       Date:  2005-01-18       Impact factor: 5.157

4.  Satisfying hydrogen bonding potential in proteins.

Authors:  I K McDonald; J M Thornton
Journal:  J Mol Biol       Date:  1994-05-20       Impact factor: 5.469

5.  Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme.

Authors:  Thomas Dierks; Achim Dickmanns; Andrea Preusser-Kunze; Bernhard Schmidt; Malaiyalam Mariappan; Kurt von Figura; Ralf Ficner; Markus Georg Rudolph
Journal:  Cell       Date:  2005-05-20       Impact factor: 41.582

6.  Conversion of cysteine to formylglycine in eukaryotic sulfatases occurs by a common mechanism in the endoplasmic reticulum.

Authors:  T Dierks; M R Lecca; B Schmidt; K von Figura
Journal:  FEBS Lett       Date:  1998-02-13       Impact factor: 4.124

7.  Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum.

Authors:  J Fey; M Balleininger; L V Borissenko; B Schmidt; K von Figura; T Dierks
Journal:  J Biol Chem       Date:  2001-10-12       Impact factor: 5.157

8.  Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme.

Authors:  Thomas Dierks; Bernhard Schmidt; Ljudmila V Borissenko; Jianhe Peng; Andrea Preusser; Malaiyalam Mariappan; Kurt von Figura
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

9.  Sulphatase activities are regulated by the interaction of sulphatase-modifying factor 1 with SUMF2.

Authors:  Ester Zito; Alessandro Fraldi; Stefano Pepe; Ida Annunziata; Gary Kobinger; Paola Di Natale; Andrea Ballabio; Maria Pia Cosma
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

10.  The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.

Authors:  Maria Pia Cosma; Stefano Pepe; Ida Annunziata; Robert F Newbold; Markus Grompe; Giancarlo Parenti; Andrea Ballabio
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

View more
  38 in total

Review 1.  Enzymatic labeling of proteins: techniques and approaches.

Authors:  Mohammad Rashidian; Jonathan K Dozier; Mark D Distefano
Journal:  Bioconjug Chem       Date:  2013-08-21       Impact factor: 4.774

2.  X-ray structure of an AdoMet radical activase reveals an anaerobic solution for formylglycine posttranslational modification.

Authors:  Peter J Goldman; Tyler L Grove; Lauren A Sites; Martin I McLaughlin; Squire J Booker; Catherine L Drennan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

3.  Conservation of the C-type lectin fold for massive sequence variation in a Treponema diversity-generating retroelement.

Authors:  Johanne Le Coq; Partho Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

4.  SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Eva Charlotte Ennemann; Karthikeyan Radhakrishnan; Bernhard Schmidt; Anupam Chakrapani; Hans-Jürgen Christen; Hugo Moser; Beat Steinmann; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2011-01-12       Impact factor: 4.246

5.  Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.

Authors:  Sumit Bhattacharyya; Xiaolu Zhang; Leo Feferman; David Johnson; Frank C Tortella; Marina Guizzetti; Joanne K Tobacman
Journal:  J Neurochem       Date:  2015-06-28       Impact factor: 5.372

6.  Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.

Authors:  Kumar Kotlo; Sumit Bhattacharyya; Bo Yang; Leonid Feferman; Shah Tejaskumar; Robert Linhardt; Robert Danziger; Joanne K Tobacman
Journal:  Glycoconj J       Date:  2013-02-06       Impact factor: 2.916

7.  Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency.

Authors:  Lars Schlotawa; Karthikeyan Radhakrishnan; Matthias Baumgartner; Regula Schmid; Bernhard Schmidt; Thomas Dierks; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

8.  Structural basis for cofactor-independent dioxygenation of N-heteroaromatic compounds at the alpha/beta-hydrolase fold.

Authors:  Roberto A Steiner; Helge J Janssen; Pietro Roversi; Aaron J Oakley; Susanne Fetzner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase.

Authors:  Carlos J Alméciga-Díaz; Maria A Rueda-Paramo; Angela J Espejo; Olga Y Echeverri; Adriana Montaño; Shunji Tomatsu; Luis A Barrera
Journal:  Mol Biol Rep       Date:  2008-11-07       Impact factor: 2.316

10.  New aldehyde tag sequences identified by screening formylglycine generating enzymes in vitro and in vivo.

Authors:  Jason S Rush; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2008-08-23       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.